The Whelan Lab
Research in the Whelan lab is motivated by the need to detect and treat ovarian cancer in its early stages. We approach the problem of ovarian cancer detection with a diverse tool kit drawn from bioanalytical chemistry, molecular biology, bioinformatics, and nanoscience.
Recent Whelan Group News
July 17, 2026 - Today, Caitlin presented a poster "In silico assisted epitope mapping of an ovarian cancer biomarker (CA125) enabled by de novo sequencing" at the University of Kansas Cancer Center (KUCC) Summer Research Symposium. Attendees of the conference included Dr. William Jewell, a long-time surgeon and early leader of KUCC, for whom the Jewell Fellowship that supported Caitlin this summer is named. It was a great opportunity to share our science and thank Dr. Jewell for his support!
June 26, 2026 - This week, Rebecca and Anubhuti were in beautiful Newport, RI for the Gordon Research Conference on Bioanalytical Sensors. Rebecca was one of the co-Chairs, and Anubhuti gave a poster presentation. Great science in an amazing setting!
June 6, 2026 - Our most recent publication, "Polyclonal antibodies targeting defined epitopes on cancer biomarker MUC16," has appeared in Analytical and Bioanalytical Chemistry as part of the topical collection Emerging Capabilities in Microscale Separations and Bioanalysis. Congratulations to the multi-institutional collaborative team!
May 26, 2026 - Today we welcome Pandora Freeman, a student from Bethel College who is joining our lab for the summer as Chemistry REU student. Welcome, Pandora; we look forward to doing great science with you!